These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 10732752

  • 1. Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes.
    Soufir N, Bressac-de Paillerets B, Desjardins L, Lévy C, Bombled J, Gorin I, Schlienger P, Stoppa-Lyonnet D.
    Br J Cancer; 2000 Feb; 82(4):818-22. PubMed ID: 10732752
    [Abstract] [Full Text] [Related]

  • 2. Lack of germ-line mutations of CDK4, p16(INK4A), and p15(INK4B) in families with glioma.
    Gao L, Liu L, van Meyel D, Cairncross G, Forsyth P, Kimmel D, Jenkins RB, Lassam NJ, Hogg D.
    Clin Cancer Res; 1997 Jun; 3(6):977-81. PubMed ID: 9815774
    [Abstract] [Full Text] [Related]

  • 3. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
    Edmunds SC, Kelsell DP, Hungerford JL, Cree IA.
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501
    [Abstract] [Full Text] [Related]

  • 4. Melanoma candidate genes CDKN2A/p16/INK4A, p14ARF, and CDK4 sequencing in patients with uveal melanoma with relative high-risk for hereditary cancer predisposition.
    Abdel-Rahman MH, Pilarski R, Massengill JB, Christopher BN, Noss R, Davidorf FH.
    Melanoma Res; 2011 Jun; 21(3):175-9. PubMed ID: 21412176
    [Abstract] [Full Text] [Related]

  • 5. Lack of germline CDK6 mutations in familial melanoma.
    Shennan MG, Badin AC, Walsh S, Summers A, From L, McKenzie M, Goldstein AM, Tucker MA, Hogg D, Lassam N.
    Oncogene; 2000 Mar 30; 19(14):1849-52. PubMed ID: 10777219
    [Abstract] [Full Text] [Related]

  • 6. CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation.
    Della Torre G, Pasini B, Frigerio S, Donghi R, Rovini D, Delia D, Peters G, Huot TJ, Bianchi-Scarra G, Lantieri F, Rodolfo M, Parmiani G, Pierotti MA.
    Br J Cancer; 2001 Sep 14; 85(6):836-44. PubMed ID: 11556834
    [Abstract] [Full Text] [Related]

  • 7. [The INK4a-ARF locus: role in the genetic predisposition to familial melanoma and in skin carcinogenesis].
    Soufir N, Basset-Seguin N.
    Bull Cancer; 2001 Nov 14; 88(11):1061-7. PubMed ID: 11741799
    [Abstract] [Full Text] [Related]

  • 8. Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi.
    Smith JH, Padnick-Silver L, Newlin A, Rhodes K, Rubinstein WS.
    Ophthalmology; 2007 Apr 14; 114(4):774-9. PubMed ID: 17207529
    [Abstract] [Full Text] [Related]

  • 9. Contribution of CDKN2A/P16 ( INK4A ), P14 (ARF), CDK4 and BRCA1/2 germline mutations in individuals with suspected genetic predisposition to uveal melanoma.
    Buecher B, Gauthier-Villars M, Desjardins L, Lumbroso-Le Rouic L, Levy C, De Pauw A, Bombled J, Tirapo C, Houdayer C, Bressac-de Paillerets B, Stoppa-Lyonnet D.
    Fam Cancer; 2010 Dec 14; 9(4):663-7. PubMed ID: 20842456
    [Abstract] [Full Text] [Related]

  • 10. CDKN2A (P16(INK4a)) and CDK4 mutation analysis in 131 Australian melanoma probands: effect of family history and multiple primary melanomas.
    Holland EA, Schmid H, Kefford RF, Mann GJ.
    Genes Chromosomes Cancer; 1999 Aug 14; 25(4):339-48. PubMed ID: 10398427
    [Abstract] [Full Text] [Related]

  • 11. Contribution of germline mutations in BRCA2, P16(INK4A), P14(ARF) and P15 to uveal melanoma.
    Hearle N, Damato BE, Humphreys J, Wixey J, Green H, Stone J, Easton DF, Houlston RS.
    Invest Ophthalmol Vis Sci; 2003 Feb 14; 44(2):458-62. PubMed ID: 12556369
    [Abstract] [Full Text] [Related]

  • 12. Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma.
    Ohta M, Nagai H, Shimizu M, Rasio D, Berd D, Mastrangelo M, Singh AD, Shields JA, Shields CL, Croce CM.
    Cancer Res; 1994 Oct 15; 54(20):5269-72. PubMed ID: 7923152
    [Abstract] [Full Text] [Related]

  • 13. Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma.
    Laud K, Marian C, Avril MF, Barrois M, Chompret A, Goldstein AM, Tucker MA, Clark PA, Peters G, Chaudru V, Demenais F, Spatz A, Smith MW, Lenoir GM, Bressac-de Paillerets B, French Hereditary Melanoma Study Group.
    J Med Genet; 2006 Jan 15; 43(1):39-47. PubMed ID: 15937071
    [Abstract] [Full Text] [Related]

  • 14. CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas.
    Hashemi J, Platz A, Ueno T, Stierner U, Ringborg U, Hansson J.
    Cancer Res; 2000 Dec 15; 60(24):6864-7. PubMed ID: 11156381
    [Abstract] [Full Text] [Related]

  • 15. Germline mutations of the INK4a-ARF gene in patients with suspected genetic predisposition to melanoma.
    Soufir N, Lacapere JJ, Bertrand G, Matichard E, Meziani R, Mirebeau D, Descamps V, Gérard B, Archimbaud A, Ollivaud L, Bouscarat F, Baccard M, Lanternier G, Saïag P, Lebbé C, Basset-Seguin N, Crickx B, Cave H, Grandchamp B.
    Br J Cancer; 2004 Jan 26; 90(2):503-9. PubMed ID: 14735200
    [Abstract] [Full Text] [Related]

  • 16. eMelanoBase: an online locus-specific variant database for familial melanoma.
    Fung DC, Holland EA, Becker TM, Hayward NK, Bressac-de Paillerets B, Mann GJ, Melanoma Genetics Consortium.
    Hum Mutat; 2003 Jan 26; 21(1):2-7. PubMed ID: 12497626
    [Abstract] [Full Text] [Related]

  • 17. A melanoma-associated germline mutation in exon 1beta inactivates p14ARF.
    Rizos H, Puig S, Badenas C, Malvehy J, Darmanian AP, Jiménez L, Milà M, Kefford RF.
    Oncogene; 2001 Sep 06; 20(39):5543-7. PubMed ID: 11571653
    [Abstract] [Full Text] [Related]

  • 18. CDKN2A point mutations D153spl(c.457G>T) and IVS2+1G>T result in aberrant splice products affecting both p16INK4a and p14ARF.
    Rutter JL, Goldstein AM, Dávila MR, Tucker MA, Struewing JP.
    Oncogene; 2003 Jul 10; 22(28):4444-8. PubMed ID: 12853981
    [Abstract] [Full Text] [Related]

  • 19. A CDKN2A mutation in familial melanoma that abrogates binding of p16INK4a to CDK4 but not CDK6.
    Jones R, Ruas M, Gregory F, Moulin S, Delia D, Manoukian S, Rowe J, Brookes S, Peters G.
    Cancer Res; 2007 Oct 01; 67(19):9134-41. PubMed ID: 17909018
    [Abstract] [Full Text] [Related]

  • 20. Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma.
    Tachibana I, Smith JS, Sato K, Hosek SM, Kimmel DW, Jenkins RB.
    Am J Med Genet; 2000 May 15; 92(2):136-41. PubMed ID: 10797439
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.